Update shared on10 Oct 2025
Fair value Increased 1.70%Narrative Update on China Pacific Insurance (Group)
Analysts have raised their price target for China Pacific Insurance (Group) from ¥41.55 to ¥42.26, citing improved margin outlook and a modest recalibration of discount rates.
What's in the News
- Amendments to the Articles of Association were approved during the Extraordinary General Meeting held on August 29, 2025 (Key Developments)
- The Board Meeting on August 28, 2025, reviewed and approved interim results for the six months ended June 30, 2025, and considered other business matters (Key Developments)
- The Extraordinary Shareholders Meeting on August 29, 2025, discussed the proposed dissolution of the Board of Supervisors and multiple amendments to company rules and procedures (Key Developments)
- NFRA approved significant amendments to the Articles of Association, impacting matters such as capital changes, acquisitions, and major asset transactions (Key Developments)
Valuation Changes
- The consensus analyst price target has risen slightly from CN¥41.55 to CN¥42.26.
- The discount rate increased modestly from 7.26% to 7.34%.
- The revenue growth projection remains largely unchanged at approximately 8.42%.
- The net profit margin improved marginally from 13.95% to 14.03%.
- The future P/E ratio edged up from 8.69x to 8.81x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.